BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia. 2007;48:1223-1244. [PMID: 17386054 DOI: 10.1111/j.1528-1167.2007.01041.x] [Cited by in Crossref: 234] [Cited by in F6Publishing: 157] [Article Influence: 16.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang Q, Zhou JQ, Zhou LM, Chen ZY, Fang ZY, Chen SD, Yang LB, Cai XD, Dai QL, Hong H, Wang HX. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure 2011;20:446-8. [PMID: 21397523 DOI: 10.1016/j.seizure.2011.02.003] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 8.1] [Reference Citation Analysis]
2 Trinka E, Höfler J, Leitinger M, Brigo F. Pharmacotherapy for Status Epilepticus. Drugs 2015;75:1499-521. [PMID: 26310189 DOI: 10.1007/s40265-015-0454-2] [Cited by in Crossref: 111] [Cited by in F6Publishing: 72] [Article Influence: 22.2] [Reference Citation Analysis]
3 Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur J Clin Pharmacol 2011;67:463-70. [DOI: 10.1007/s00228-011-1005-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
4 Błaszczyk B, Szpringer M, Czuczwar SJ, Lasoń W. Single centre 20 year survey of antiepileptic drug-induced hypersensitivity reactions. Pharmacol Rep 2013;65:399-409. [PMID: 23744424 DOI: 10.1016/s1734-1140(13)71015-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.9] [Reference Citation Analysis]
5 Perucca E. The treatment of the first seizure: The risks: Risks in Treating a First Seizure. Epilepsia 2008;49:29-34. [DOI: 10.1111/j.1528-1167.2008.01447.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ahmed AM, Pritchard S, Reichenberg J. A review of cutaneous drug eruptions. Clin Geriatr Med 2013;29:527-45. [PMID: 23571043 DOI: 10.1016/j.cger.2013.01.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
7 Gidal BE. Carbamazepine hypersensitivity: progress toward predicting the unpredictable. Epilepsy Curr 2011;11:189-91. [PMID: 22129846 DOI: 10.5698/1535-7511-11.6.189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
8 Lv YD, Min FL, Liao WP, He N, Zeng T, Ma DH, Shi YW. The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a northern Han Chinese population. BMC Neurol 2013;13:75. [PMID: 23829937 DOI: 10.1186/1471-2377-13-75] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
9 Franco V, Perucca E. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. Expert Opinion on Drug Metabolism & Toxicology 2015;11:1269-79. [DOI: 10.1517/17425255.2015.1053463] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
10 Atanasković-Marković M, Janković J, Tmušić V, Gavrović-Jankulović M, Ćirković Veličković T, Nikolić D, Škorić D. Hypersensitivity reactions to antiepileptic drugs in children. Pediatr Allergy Immunol 2019;30:547-52. [PMID: 30951222 DOI: 10.1111/pai.13055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Rieder MJ. Immune mediation of hypersensitivity adverse drug reactions: implications for therapy. Expert Opin Drug Saf 2009;8:331-43. [PMID: 19505265 DOI: 10.1517/14740330902933736] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
12 Uribe-San-Martín R, Ciampi E, Uslar W, Villagra S, Plaza J, Godoy J, Mellado P. Risk factors of early adverse drug reactions with phenytoin: A prospective inpatient cohort. Epilepsy Behav 2017;76:139-44. [PMID: 28927713 DOI: 10.1016/j.yebeh.2017.08.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
13 Martins I, Marques M, Antunes A. Protein adducts from carbamazepine-10,11-epoxide, the major metabolite of the antiepileptic drug carbamazepine: possible biomarkers of toxicity. Toxicology Letters 2015;238:S359. [DOI: 10.1016/j.toxlet.2015.08.1024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Raspall-chaure M, Neville BG, Scott RC. The medical management of the epilepsies in children: conceptual and practical considerations. The Lancet Neurology 2008;7:57-69. [DOI: 10.1016/s1474-4422(07)70324-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
15 Ye YM, Thong BY, Park HS. Hypersensitivity to antiepileptic drugs. Immunol Allergy Clin North Am 2014;34:633-43, ix. [PMID: 25017681 DOI: 10.1016/j.iac.2014.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
16 Elzagallaai AA, Knowles SR, Rieder MJ, Bend JR, Shear NH, Koren G. Patch Testing for the Diagnosis of Anticonvulsant Hypersensitivity Syndrome: A Systematic Review. Drug Safety 2009;32:391-408. [DOI: 10.2165/00002018-200932050-00003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
17 Tsuchiya N, Narita S, Inoue T, Hasunuma N, Numakura K, Horikawa Y, Satoh S, Notoya T, Fujishima N, Hatakeyama S, Ohyama C, Habuchi T. Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma. Anticancer Drugs. 2013;24:310-314. [PMID: 23237922 DOI: 10.1097/cad.0b013e32835c401c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
18 Zaccara G. Neurological comorbidity and epilepsy: implications for treatment. Acta Neurol Scand 2009;120:1-15. [PMID: 19527225 DOI: 10.1111/j.1600-0404.2008.01146.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
19 Verrotti A, Tambucci R, Di Francesco L, Pavone P, Iapadre G, Altobelli E, Matricardi S, Farello G, Belcastro V. The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection. Expert Rev Neurother 2020;20:167-73. [PMID: 31855066 DOI: 10.1080/14737175.2020.1707668] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
20 Elzagallaai AA, Knowles SR, Rieder MJ, Bend JR, Shear NH, Koren G. In Vitro Testing for the Diagnosis of Anticonvulsant Hypersensitivity Syndrome: A Systematic Review. Mol Diag Ther 2009;13:313-30. [DOI: 10.1007/bf03256336] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
21 Sadan O, Seyman E, Ash EL, Kipervasser S, Neufeld MY. Adult-onset temporal lobe epilepsy, cognitive decline, multi-antiepileptic drug hypersensitivity, and Hashimoto's encephalopathy: Two case studies. Epilepsy Behav Case Rep 2013;1:132-5. [PMID: 25667846 DOI: 10.1016/j.ebcr.2013.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
22 Ben-cherif W, Dridi I, Hassine M, Ben-attia M, Aouam K, Reinberg A, Boughattas N. Circadian haematotoxicity of the antiepileptic valproic acid in mice. J Appl Biomed 2014;12:31-8. [DOI: 10.1016/j.jab.2013.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Schmidt D. Drug treatment of epilepsy: options and limitations. Epilepsy Behav 2009;15:56-65. [PMID: 19236951 DOI: 10.1016/j.yebeh.2009.02.030] [Cited by in Crossref: 88] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
24 Egunsola O, Choonara I, Sammons HM. Safety of lamotrigine in paediatrics: a systematic review. BMJ Open 2015;5:e007711. [PMID: 26070796 DOI: 10.1136/bmjopen-2015-007711] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
25 Nabukenya AM, Matovu JK, Wabwire-Mangen F, Wanyenze RK, Makumbi F. Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study. Health Qual Life Outcomes 2014;12:49. [PMID: 24725904 DOI: 10.1186/1477-7525-12-49] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
26 Zaccara G, Giovannelli F, Cincotta M, Iudice A. AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel. Expert Rev Neurother 2013;13:647-55. [PMID: 23739002 DOI: 10.1586/ern.13.46] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
27 Wang X, Chao L, Liu X, Xu X, Zhang Q. Association Between HLA Genotype and Cutaneous Adverse Reactions to Antiepileptic Drugs Among Epilepsy Patients in Northwest China. Front Neurol 2019;10:1. [PMID: 30761061 DOI: 10.3389/fneur.2019.00001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 14.0] [Reference Citation Analysis]
28 Park SP. Depression in patients with newly diagnosed epilepsy predicts lamotrigine-induced rash: a short-term observational study. Epilepsy Behav 2013;28:88-90. [PMID: 23673289 DOI: 10.1016/j.yebeh.2013.03.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Abou-khalil B, Schmidt D. Antiepileptic drugs. Epilepsy. Elsevier; 2012. pp. 723-39. [DOI: 10.1016/b978-0-444-52899-5.00024-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
30 Guilhoto LM, Loddenkemper T, Gooty VD, Rotenberg A, Takeoka M, Duffy FH, Coulter D, Urion D, Bourgeois BF, Kothare SV. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Pediatr Neurol 2011;44:414-9. [PMID: 21555051 DOI: 10.1016/j.pediatrneurol.2010.12.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
31 Shi YW, Min FL, Liu XR, Zan LX, Gao MM, Yu MJ, Liao WP. Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population. Basic Clin Pharmacol Toxicol 2011;109:42-6. [PMID: 21306565 DOI: 10.1111/j.1742-7843.2011.00681.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
32 Guvenir H, Dibek Misirlioglu E, Civelek E, Toyran M, Buyuktiryaki B, Ginis T, Capanoglu M, Gurkas E, Guven A, Kocabas CN. The Frequency and Clinical Features of Hypersensitivity Reactions to Antiepileptic Drugs in Children: A Prospective Study. J Allergy Clin Immunol Pract 2018;6:2043-50. [PMID: 29501520 DOI: 10.1016/j.jaip.2018.02.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
33 Park CS, Kang DY, Kang MG, Kim S, Ye YM, Kim SH, Park HK, Park JW, Nam YH, Yang MS, Jee YK, Jung JW, Kim SH, Kim CW, Kim MY, Kim JH, Lee J, Lee JG, Kim SH, La HO, Kim MH, Park SJ, Koh YI, Lee SM, Kwon YE, Jin HJ, Kim HK, Kang HR, Choi JH; Korean Registry of Severe Cutaneous Adverse Reactions Consortium. Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea. Allergy Asthma Immunol Res 2019;11:709-22. [PMID: 31332981 DOI: 10.4168/aair.2019.11.5.709] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
34 Steinhoff BJ. Cenobamate tablets as a treatment for focal-onset seizures in adults. Expert Rev Clin Pharmacol 2021;14:161-72. [PMID: 33470139 DOI: 10.1080/17512433.2021.1879637] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Shawcross D, Auzinger G. Lamotrigine and the risk of fulminant hepatic failure. The Lancet 2008;371:649-50. [DOI: 10.1016/s0140-6736(08)60300-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Merrick BA. The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research. Brief Funct Genomic Proteomic 2008;7:35-49. [PMID: 18270218 DOI: 10.1093/bfgp/eln004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
37 Du Y, Lin J, Shen J, Ding S, Ye M, Wang L, Wang Y, Wang X, Xia N, Zheng R, Chen H, Xu H. Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015. BMC Pharmacol Toxicol 2019;20:7. [PMID: 30642405 DOI: 10.1186/s40360-019-0285-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
38 Perucca E, French J, Bialer M. Development of new antiepileptic drugs: challenges, incentives, and recent advances. The Lancet Neurology 2007;6:793-804. [DOI: 10.1016/s1474-4422(07)70215-6] [Cited by in Crossref: 235] [Cited by in F6Publishing: 60] [Article Influence: 16.8] [Reference Citation Analysis]
39 Błaszczyk B, Lasoń W, Czuczwar SJ. Antiepileptic drugs and adverse skin reactions: An update. Pharmacological Reports 2015;67:426-34. [DOI: 10.1016/j.pharep.2014.11.009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 10.5] [Reference Citation Analysis]
40 Vernillet L, Greene SA, Kamin M. Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending‐Dose Studies in Healthy Subjects. Clinical Pharmacology in Drug Development 2020;9:428-43. [DOI: 10.1002/cpdd.769] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
41 Hung WY, Abreu Lanfranco O. Contemporary review of drug-induced pancreatitis: A different perspective. World J Gastrointest Pathophysiol. 2014;5:405-415. [PMID: 25400984 DOI: 10.4291/wjgp.v5.i4.405] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 29] [Article Influence: 7.1] [Reference Citation Analysis]
42 Riikonen R, Rener-Primec Z, Carmant L, Dorofeeva M, Hollody K, Szabo I, Krajnc BS, Wohlrab G, Sorri I. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study. Dev Med Child Neurol 2015;57:60-7. [PMID: 25145415 DOI: 10.1111/dmcn.12573] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
43 Sun FT, Morrell MJ. The RNS System: responsive cortical stimulation for the treatment of refractory partial epilepsy. Expert Review of Medical Devices 2014;11:563-72. [DOI: 10.1586/17434440.2014.947274] [Cited by in Crossref: 109] [Cited by in F6Publishing: 76] [Article Influence: 15.6] [Reference Citation Analysis]
44 Suzuki Y, Fukuda M, Tohyama M, Ishikawa M, Yasukawa M, Ishii E. Carbamazepine-induced drug-induced hypersensitivity syndrome in a 14-year-old Japanese boy. Epilepsia 2008;49:2118-21. [DOI: 10.1111/j.1528-1167.2008.01785.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
45 Godhwani N, Bahna SL. Antiepilepsy drugs and the immune system. Ann Allergy Asthma Immunol 2016;117:634-40. [PMID: 27979020 DOI: 10.1016/j.anai.2016.09.443] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
46 Guinan EC. Acquired aplastic anemia in childhood. Hematol Oncol Clin North Am 2009;23:171-91. [PMID: 19327578 DOI: 10.1016/j.hoc.2009.01.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
47 Zaccara G, Giannasi G, Oggioni R, Rosati E, Tramacere L, Palumbo P. Challenges in the treatment of convulsive status epilepticus. Seizure 2017;47:17-24. [DOI: 10.1016/j.seizure.2017.02.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 7.8] [Reference Citation Analysis]
48 Alkhotani A, McLachlan RS. Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine. Seizure 2012;21:407-8. [PMID: 22524985 DOI: 10.1016/j.seizure.2012.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
49 Zaccara G, Schmidt D. Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development. Pharmacological Research 2016;104:38-48. [DOI: 10.1016/j.phrs.2015.12.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
50 Jain A, Haque I, Tayal V, Roy V. Valproic acid-induced acute pancreatitis. Indian J Psychiatry 2019;61:421-2. [PMID: 31391650 DOI: 10.4103/psychiatry.IndianJPsychiatry_383_18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
51 Scott TN, Bailin HG, Jutkowitz LA, Scott MA, Lucidi CA. Bone marrow, blood, and clinical findings in dogs treated with phenobarbital. Vet Clin Pathol 2021;50:122-31. [PMID: 33751634 DOI: 10.1111/vcp.13013] [Reference Citation Analysis]
52 Wahab A. Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development. Pharmaceuticals (Basel) 2010;3:2090-110. [PMID: 27713344 DOI: 10.3390/ph3072090] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
53 Handoko KB, van Puijenbroek EP, Bijl AH, Hermens WAJJ, Zwart-van rijkom JEF, Hekster YA, Egberts TCG. Influence of Chemical Structure on Hypersensitivity Reactions Induced by Antiepileptic Drugs: The Role of the Aromatic Ring. Drug Safety 2008;31:695-702. [DOI: 10.2165/00002018-200831080-00006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
54 Bosak M, Porębski G, Słowik A, Turaj W. Common allergies do not influence the prevalence of cutaneous hypersensitivity reactions to antiepileptic drugs. Epilepsy Res 2017;135:9-13. [PMID: 28552676 DOI: 10.1016/j.eplepsyres.2017.05.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
55 Zaccara G, Giovannelli F, Cincotta M, Carelli A, Verrotti A. Clinical utility of eslicarbazepine: current evidence. Drug Des Devel Ther 2015;9:781-9. [PMID: 25709402 DOI: 10.2147/DDDT.S57409] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 4.2] [Reference Citation Analysis]
56 Shirzadi M, Saunes M, Reimers A, Brodtkorb E. Rash during lamotrigine treatment is not always drug hypersensitivity: A retrospective cohort study among children and adults. Seizure 2021;89:12-8. [PMID: 33951602 DOI: 10.1016/j.seizure.2021.04.015] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Striano P, Zara F. HLA alleles linked to carbamazepine hypersensitivity. Nat Rev Neurol 2011;7:365-6. [DOI: 10.1038/nrneurol.2011.90] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
58 Chan R, Wei CY, Chen YT, Benet LZ. Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage. AAPS J 2016;18:757-66. [PMID: 26951484 DOI: 10.1208/s12248-016-9898-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
59 Curia G, Biagini G, Perucca E, Avoli M. Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs 2009;23:555-68. [PMID: 19552484 DOI: 10.2165/00023210-200923070-00002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
60 Schnackenberg LK, Kaput J, Beger RD. Metabolomics: a tool for personalizing medicine? Personalized Medicine 2008;5:495-504. [DOI: 10.2217/17410541.5.5.495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Packer RMA, Volk HA. Epilepsy beyond seizures: a review of the impact of epilepsy and its comorbidities on health-related quality of life in dogs. Veterinary Record 2015;177:306-15. [DOI: 10.1136/vr.103360] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
62 Egunsola O, Choonara I, Sammons HM, Whitehouse WP. Safety of antiepileptic drugs in children and young people: A prospective cohort study. Seizure 2018;56:20-5. [DOI: 10.1016/j.seizure.2018.01.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
63 Beghi E. Treating epilepsy across its different stages. Ther Adv Neurol Disord 2010;3:85-92. [PMID: 21179601 DOI: 10.1177/1756285609351945] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
64 Mani R, Monteleone C, Schalock PC, Truong T, Zhang XB, Wagner ML. Rashes and other hypersensitivity reactions associated with antiepileptic drugs: A review of current literature. Seizure 2019;71:270-8. [PMID: 31491658 DOI: 10.1016/j.seizure.2019.07.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
65 Perucca P, Jacoby A, Marson AG, Baker GA, Lane S, Benn EK, Thurman DJ, Hauser WA, Gilliam FG, Hesdorffer DC. Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology 2011;76:273-9. [PMID: 21242496 DOI: 10.1212/WNL.0b013e318207b073] [Cited by in Crossref: 59] [Cited by in F6Publishing: 13] [Article Influence: 5.9] [Reference Citation Analysis]
66 Mogami Y, Takahashi Y, Takayama R, Ohtani H, Ikeda H, Imai K, Shigematu H, Inoue Y. Cutaneous adverse drug reaction in patients with epilepsy after acute encephalitis. Brain and Development 2012;34:496-503. [DOI: 10.1016/j.braindev.2011.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
67 Nabatame S, Saito Y, Sakuma H, Komaki H, Nakagawa E, Sugai K, Sasaki M, Uchiyama K, Kosaka M. Bromoderma in a patient with migrating partial seizures in infancy. Epilepsy Research 2010;91:283-8. [DOI: 10.1016/j.eplepsyres.2010.07.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
68 Zaccara G, Giorgi FS, Amantini A, Giannasi G, Campostrini R, Giovannelli F, Paganini M, Nazerian P; the Tuscany study group on seizures in the emergency department and status epilepticus in adults. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus. Acta Neurol Scand 2018;137:618-22. [DOI: 10.1111/ane.12928] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
69 Santos BLD, Fernandes RMF, Neves FF. Valproic acid-induced pancreatitis in an adult. Arq Neuro-Psiquiatr 2010;68:135-6. [DOI: 10.1590/s0004-282x2010000100029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Gunia-Krzyżak A, Żesławska E, Słoczyńska K, Koczurkiewicz P, Nitek W, Żelaszczyk D, Szkaradek N, Waszkielewicz AM, Pękala E, Marona H. Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols. Eur J Med Chem 2016;107:26-37. [PMID: 26560050 DOI: 10.1016/j.ejmech.2015.10.051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
71 Smith TL, Baldwin A, Cunningham LL Jr, Cook AM. Rash associated with pregabalin use. Ann Pharmacother 2008;42:1899-902. [PMID: 19001532 DOI: 10.1345/aph.1L305] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
72 De Luca F, Losappio LM, Mirone C, Schroeder JW, Citterio A, Aversano MG, Scibilia J, Pastorello EA. Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature. Clin Mol Allergy 2017;15:16. [PMID: 29026345 DOI: 10.1186/s12948-017-0072-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
73 Santos NA, Medina WS, Martins NM, Mingatto FE, Curti C, Santos AC. Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver. Toxicol In Vitro 2008;22:1143-52. [PMID: 18434079 DOI: 10.1016/j.tiv.2008.03.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
74 Stephen LJ, Brodie MJ. Antiepileptic drug monotherapy versus polytherapy: pursuing seizure freedom and tolerability in adults. Curr Opin Neurol 2012;25:164-72. [PMID: 22322411 DOI: 10.1097/WCO.0b013e328350ba68] [Cited by in Crossref: 56] [Cited by in F6Publishing: 16] [Article Influence: 6.2] [Reference Citation Analysis]
75 Al-Sinani S, Al-Rawas A, Dhawan A. Mercury as a cause of fulminant hepatic failure in a child: case report and literature review. Clin Res Hepatol Gastroenterol 2011;35:580-2. [PMID: 21820988 DOI: 10.1016/j.clinre.2011.06.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
76 Charalambous M, Pakozdy A, Bhatti SFM, Volk HA. Systematic review of antiepileptic drugs' safety and effectiveness in feline epilepsy. BMC Vet Res 2018;14:64. [PMID: 29499762 DOI: 10.1186/s12917-018-1386-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
77 Mori F, Blanca‐lopez N, Caubet J, Demoly P, Du Toit G, Gomes ER, Kuyucu S, Romano A, Soyer O, Tsabouri S, Atanaskovic‐markovic M, Eigenmann P. Delayed hypersensitivity to antiepileptic drugs in children. Pediatr Allergy Immunol 2021;32:425-36. [DOI: 10.1111/pai.13409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
78 Song JS, Kang ES, Joo EY, Hong SB, Seo DW, Lee SY. Absence of HLA-B*1502 and HLA-A*3101 alleles in 9 Korean patients with antiepileptic drug-induced skin rash: a preliminary study. Ann Lab Med 2014;34:372-5. [PMID: 25187890 DOI: 10.3343/alm.2014.34.5.372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
79 Liaw GW, Hung DZ, Chen WK, Lin CL, Lin IC, Kao CH. Relationship Between Acute Benzodiazepine Poisoning and Acute Pancreatitis Risk: A Population-Based Cohort Study. Medicine (Baltimore) 2015;94:e2376. [PMID: 26717383 DOI: 10.1097/MD.0000000000002376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
80 Cramer JA, Mintzer S, Wheless J, Mattson RH. Adverse effects of antiepileptic drugs: a brief overview of important issues. Expert Review of Neurotherapeutics 2014;10:885-91. [DOI: 10.1586/ern.10.71] [Cited by in Crossref: 95] [Cited by in F6Publishing: 77] [Article Influence: 13.6] [Reference Citation Analysis]
81 Iida A, Sasaki E, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats. Drug Metab Dispos 2015;43:958-68. [DOI: 10.1124/dmd.115.063370] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
82 Guerrini R, Zaccara G, la Marca G, Rosati A. Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy: . Drug Safety 2012;35:519-33. [DOI: 10.2165/11630700-000000000-00000] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
83 Fricke-Galindo I, LLerena A, Jung-Cook H, López-López M. Carbamazepine adverse drug reactions. Expert Rev Clin Pharmacol 2018;11:705-18. [PMID: 29898616 DOI: 10.1080/17512433.2018.1486707] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 9.7] [Reference Citation Analysis]
84 Saruwatari J, Ishitsu T, Nakagawa K. Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy. Pharmaceuticals (Basel) 2010;3:2709-32. [PMID: 27713373 DOI: 10.3390/ph3082709] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
85 Kuyucu S, Caubet J. Hypersensitivity Reactions to Antiepileptic Drugs in Children: Epidemiologic, Pathogenetic, Clinical, and Diagnostic Aspects. The Journal of Allergy and Clinical Immunology: In Practice 2018;6:1879-1891.e1. [DOI: 10.1016/j.jaip.2018.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
86 Striano P, Striano S. New and investigational antiepileptic drugs. Expert Opin Investig Drugs 2009;18:1875-84. [PMID: 19938901 DOI: 10.1517/13543780903369341] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
87 Zaccara G, Tramacere L, Cincotta M. Drug safety evaluation of zonisamide for the treatment of epilepsy. Expert Opinion on Drug Safety 2011;10:623-31. [DOI: 10.1517/14740338.2011.571201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
88 Löscher W, Sills GJ, White HS. The ups and downs of alkyl-carbamates in epilepsy therapy: How does cenobamate differ? Epilepsia 2021;62:596-614. [PMID: 33580520 DOI: 10.1111/epi.16832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
89 Park YS, Cosgrove GR, Madsen JR, Eskandar EN, Hochberg LR, Cash SS, Truccolo W. Early Detection of Human Epileptic Seizures Based on Intracortical Microelectrode Array Signals. IEEE Trans Biomed Eng 2020;67:817-31. [PMID: 31180831 DOI: 10.1109/TBME.2019.2921448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Besli GE, Yildirim S, Yilmaz K, Yuksel E. DRESS Syndrome or Hematologic Malignancy?: A Case Report of a 4-Year-Old Boy. Pediatr Emerg Care 2017;33:494-6. [PMID: 28665895 DOI: 10.1097/PEC.0000000000000489] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
91 Kasperavičiūtė D, Sisodiya SM. Epilepsy pharmacogenetics. Pharmacogenomics 2009;10:817-36. [DOI: 10.2217/pgs.09.34] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
92 Gaitatzis A, Sander JW. The Long-Term Safety of Antiepileptic Drugs. CNS Drugs 2013;27:435-55. [DOI: 10.1007/s40263-013-0063-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 31] [Article Influence: 7.1] [Reference Citation Analysis]
93 Elger CE, Schmidt D. Modern management of epilepsy: A practical approach. Epilepsy & Behavior 2008;12:501-39. [DOI: 10.1016/j.yebeh.2008.01.003] [Cited by in Crossref: 116] [Cited by in F6Publishing: 82] [Article Influence: 8.9] [Reference Citation Analysis]
94 Shirzadi M, Alvestad S, Hovdal H, Espeset K, Lydersen S, Brodtkorb E. Comparison of carbamazepine rash in multiple sclerosis and epilepsy: Carbamazepine rash. Acta Neurologica Scandinavica 2012;125:60-3. [DOI: 10.1111/j.1600-0404.2011.01553.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
95 Hu FY, Wu XT, An DM, Yan B, Stefan H, Zhou D. Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population. Seizure 2011;20:160-2. [PMID: 21169036 DOI: 10.1016/j.seizure.2010.11.014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
96 Maheswari E, Saraswathy GR, Santhranii T. Hepatoprotective and antioxidant activity of N-acetyl cysteine in carbamazepine-administered rats. Indian J Pharmacol 2014;46:211-5. [PMID: 24741196 DOI: 10.4103/0253-7613.129321] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
97 Kaczorowska-Hac B, Matheisel A, Maciejka-Kapuscinska L, Wisniewski J, Alska A, Adamkiewicz-Drozynska E, Balcerska A, Reszczynska I. Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report. J Med Case Rep 2012;6:239. [PMID: 22883745 DOI: 10.1186/1752-1947-6-239] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
98 Heck CN, King-Stephens D, Massey AD, Nair DR, Jobst BC, Barkley GL, Salanova V, Cole AJ, Smith MC, Gwinn RP, Skidmore C, Van Ness PC, Bergey GK, Park YD, Miller I, Geller E, Rutecki PA, Zimmerman R, Spencer DC, Goldman A, Edwards JC, Leiphart JW, Wharen RE, Fessler J, Fountain NB, Worrell GA, Gross RE, Eisenschenk S, Duckrow RB, Hirsch LJ, Bazil C, O'Donovan CA, Sun FT, Courtney TA, Seale CG, Morrell MJ. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia 2014;55:432-41. [PMID: 24621228 DOI: 10.1111/epi.12534] [Cited by in Crossref: 325] [Cited by in F6Publishing: 229] [Article Influence: 46.4] [Reference Citation Analysis]
99 Sperling MR, Klein P, Aboumatar S, Gelfand M, Halford JJ, Krauss GL, Rosenfeld WE, Vossler DG, Wechsler R, Borchert L, Kamin M. Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study. Epilepsia 2020;61:1099-108. [PMID: 32396252 DOI: 10.1111/epi.16525] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 20.0] [Reference Citation Analysis]
100 Marsh O, Corsini G, Van Dijk J, Gutierrez-Quintana R, De Risio L. Prevalence and clinical characteristics of phenobarbitone-associated adverse effects in epileptic cats. J Feline Med Surg 2021;23:59-66. [PMID: 32484071 DOI: 10.1177/1098612X20924925] [Reference Citation Analysis]
101 Pastore V, Sabatier L, Enrique A, Marder M, Bruno-Blanch LE. Synthesis and anticonvulsant activity of bioisosteres of trimethadione, N-derivative-1,2,3-oxathiazolidine-4-one-2,2-dioxides from α-hydroxyamides. Bioorg Med Chem 2013;21:841-6. [PMID: 23321016 DOI: 10.1016/j.bmc.2012.12.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
102 Hakimian S, Miller JW. The Genetics of Antiepileptic Drug–Induced Skin Reactions. Clin Pharmacol Ther 2011;89:908-10. [DOI: 10.1038/clpt.2010.357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
103 Pattanaik S, Jain A, Ahluwalia J. Evolving Role of Pharmacogenetic Biomarkers to Predict Drug-Induced Hematological Disorders. Ther Drug Monit 2021;43:201-20. [PMID: 33235023 DOI: 10.1097/FTD.0000000000000842] [Reference Citation Analysis]
104 Santos N, Medina W, Martins N, Rodrigues MC, Curti C, Santos A. Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs. Toxicology in Vitro 2008;22:1820-4. [DOI: 10.1016/j.tiv.2008.08.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
105 Zaccara G, Giovannelli F, Cincotta M, Verrotti A, Grillo E. The adverse event profile of perampanel: meta-analysis of randomized controlled trials. Eur J Neurol 2013;20:1204-11. [PMID: 23607817 DOI: 10.1111/ene.12170] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
106 Strzelczyk A, Mann C, Willems LM, Rosenow F, Bauer S. Cenobamate for the treatment of focal epilepsies. Expert Opin Pharmacother 2020;21:2215-23. [PMID: 32812825 DOI: 10.1080/14656566.2020.1803830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
107 Kaur S, Dogra A. Toxic epidermal necrolysis due to concomitant use of lamotrigine and valproic Acid. Indian J Dermatol 2013;58:406. [PMID: 24082198 DOI: 10.4103/0019-5154.117319] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
108 Eun S, Kim HD, Eun B, Lee IK, Chung HJ, Kim JS, Kang H, Lee Y, Suh ES, Kim DW, Eom S, Lee JS, Moon HK. Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. Seizure 2011;20:558-63. [DOI: 10.1016/j.seizure.2011.04.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
109 Chung WH, Hung SI, Chen YT. Genetic predisposition of life-threatening antiepileptic-induced skin reactions. Expert Opin Drug Saf 2010;9:15-21. [PMID: 20001755 DOI: 10.1517/14740330903427969] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
110 Chung SS, French JA, Kowalski J, Krauss GL, Lee SK, Maciejowski M, Rosenfeld WE, Sperling MR, Mizne S, Kamin M. Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures. Neurology 2020;94:e2311-22. [PMID: 32409485 DOI: 10.1212/WNL.0000000000009530] [Cited by in Crossref: 27] [Cited by in F6Publishing: 2] [Article Influence: 27.0] [Reference Citation Analysis]
111 Rodriguez-vallecillo E, Woodbury-fariña MA. Dermatological Manifestations of Stress in Normal and Psychiatric Populations. Psychiatric Clinics of North America 2014;37:625-51. [DOI: 10.1016/j.psc.2014.08.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
112 Krauss GL, Klein P, Brandt C, Lee SK, Milanov I, Milovanovic M, Steinhoff BJ, Kamin M. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. Lancet Neurol 2020;19:38-48. [PMID: 31734103 DOI: 10.1016/S1474-4422(19)30399-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 12] [Article Influence: 25.5] [Reference Citation Analysis]
113 Bernett A, Phenis R, Fonkem E, Aceves J, Kirmani B, Cruz-Laureano D. Neurobehavioral effects of levetiracetam in brain tumor related epilepsy. Front Neurol 2013;4:99. [PMID: 23885253 DOI: 10.3389/fneur.2013.00099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
114 Rudzinski LA, Vélez-ruiz NJ, Gedzelman ER, Mauricio EA, Shih JJ, Karakis I. New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel. J Investig Med 2016;64:1087-101. [DOI: 10.1136/jim-2016-000151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
115 Shih JJ, Ochoa JG. A systematic review of antiepileptic drug initiation and withdrawal. Neurologist 2009;15:122-31. [PMID: 19430266 DOI: 10.1097/NRL.0b013e3181901ad3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
116 Zaccara G, Perucca P, Loiacono G, Giovannelli F, Verrotti A. The adverse event profile of lacosamide: A systematic review and meta-analysis of randomized controlled trials: The Adverse Event Profile of Lacosamide. Epilepsia 2013;54:66-74. [DOI: 10.1111/j.1528-1167.2012.03589.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
117 Scaparrotta A, Verrotti A, Consilvio N, Cingolani A, Di Pillo S, Di Gioacchino M, Verini M, Chiarelli F. Pathogenesis and Clinical Approaches to Anticonvulsant Hypersensitivity Syndrome: Current State of Knowledge. Int J Immunopathol Pharmacol 2011;24:277-84. [DOI: 10.1177/039463201102400201] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
118 Sharma S, Kwan P. The safety of treating newly diagnosed epilepsy. Expert Opin Drug Saf 2019;18:273-83. [PMID: 30943798 DOI: 10.1080/14740338.2019.1602607] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
119 Namazi S, Borhani-haghighi A, Karimzadeh I. Adverse Reactions to Antiepileptic Drugs in Epileptic Outpatients: A Cross-Sectional Study in Iran. Clinical Neuropharmacology 2011;34:79-83. [DOI: 10.1097/wnf.0b013e318210ece0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
120 Fattorusso A, Matricardi S, Mencaroni E, Dell'Isola GB, Di Cara G, Striano P, Verrotti A. The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies. Front Neurol 2021;12:674483. [PMID: 34239494 DOI: 10.3389/fneur.2021.674483] [Reference Citation Analysis]
121 Yılmaz Ü, Yılmaz TS, Dizdarer G, Akıncı G, Güzel O, Tekgül H. Efficacy and tolerability of the first antiepileptic drug in children with newly diagnosed idiopathic epilepsy. Seizure 2014;23:252-9. [DOI: 10.1016/j.seizure.2013.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
122 Bersan E, Volk HA, Ros C, Risio LD. Phenobarbitone-induced haematological abnormalities in idiopathic epileptic dogs: prevalence, risk factors, clinical presentation and outcome. Veterinary Record 2014;175:247-247. [DOI: 10.1136/vr.102158] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
123 Verrotti A, Loiacono G, Rossi A, Zaccara G. Eslicarbazepine acetate: An update on efficacy and safety in epilepsy. Epilepsy Research 2014;108:1-10. [DOI: 10.1016/j.eplepsyres.2013.10.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
124 Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidem Drug Safe 2009;18:483-91. [DOI: 10.1002/pds.1736] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
125 Laurenza A, Yang H, Williams B, Zhou S, Ferry J. Absence of Liver Toxicity in Perampanel-Treated Subjects: Pooled results from partial seizure phase III perampanel clinical studies. Epilepsy Research 2015;113:76-85. [DOI: 10.1016/j.eplepsyres.2015.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
126 Lee YJ, Kang HC, Seo JH, Lee JS, Kim HD. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy. Brain and Development 2010;32:208-12. [DOI: 10.1016/j.braindev.2009.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
127 Gaitatzis A, Sisodiya SM, Sander JW. The somatic comorbidity of epilepsy: A weighty but often unrecognized burden: The Somatic Comorbidity of Epilepsy. Epilepsia 2012;53:1282-93. [DOI: 10.1111/j.1528-1167.2012.03528.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 75] [Article Influence: 12.6] [Reference Citation Analysis]
128 Kiang TKL, Teng XW, Karagiozov S, Surendradoss J, Chang TKH, Abbott FS. Role of Oxidative Metabolism in the Effect of Valproic Acid on Markers of Cell Viability, Necrosis, and Oxidative Stress in Sandwich-Cultured Rat Hepatocytes. Toxicological Sciences 2010;118:501-9. [DOI: 10.1093/toxsci/kfq294] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
129 Cook AM, Bensalem-owen MK. Mechanisms of action of antiepileptic drugs. Therapy 2011;8:307-13. [DOI: 10.2217/thy.11.19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
130 Brodie MJ. Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview. CNS Drugs 2017;31:135-47. [PMID: 28101765 DOI: 10.1007/s40263-016-0406-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
131 Ramírez-gonzález MD, Herrera-enríquez M, Villanueva-rodríguez LG, Castell-rodríguez AE. Role of Epidermal Dendritic Cells in Drug-Induced Cutaneous Adverse Reactions. In: Lombardi G, Riffo-vasquez Y, editors. Dendritic Cells. Berlin: Springer Berlin Heidelberg; 2009. pp. 137-62. [DOI: 10.1007/978-3-540-71029-5_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
132 Kessler SK, McGinnis E. A Practical Guide to Treatment of Childhood Absence Epilepsy. Paediatr Drugs 2019;21:15-24. [PMID: 30734897 DOI: 10.1007/s40272-019-00325-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
133 Bergey GK, Morrell MJ, Mizrahi EM, Goldman A, King-Stephens D, Nair D, Srinivasan S, Jobst B, Gross RE, Shields DC, Barkley G, Salanova V, Olejniczak P, Cole A, Cash SS, Noe K, Wharen R, Worrell G, Murro AM, Edwards J, Duchowny M, Spencer D, Smith M, Geller E, Gwinn R, Skidmore C, Eisenschenk S, Berg M, Heck C, Van Ness P, Fountain N, Rutecki P, Massey A, O'Donovan C, Labar D, Duckrow RB, Hirsch LJ, Courtney T, Sun FT, Seale CG. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology 2015;84:810-7. [PMID: 25616485 DOI: 10.1212/WNL.0000000000001280] [Cited by in Crossref: 321] [Cited by in F6Publishing: 107] [Article Influence: 53.5] [Reference Citation Analysis]
134 Franciotta D, Kwan P, Perucca E. Genetic basis for idiosyncratic reactions to antiepileptic drugs. Current Opinion in Neurology 2009;22:144-9. [DOI: 10.1097/wco.0b013e328328f276] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
135 Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11:792-802. [PMID: 22832500 DOI: 10.1016/s1474-4422(12)70153-9] [Cited by in Crossref: 300] [Cited by in F6Publishing: 84] [Article Influence: 33.3] [Reference Citation Analysis]
136 Potschka H, Fischer A, Löscher W, Patterson N, Bhatti S, Berendt M, De Risio L, Farquhar R, Long S, Mandigers P, Matiasek K, Muñana K, Pakozdy A, Penderis J, Platt S, Podell M, Rusbridge C, Stein V, Tipold A, Volk HA. International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy. BMC Vet Res 2015;11:177. [PMID: 26314300 DOI: 10.1186/s12917-015-0465-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 6.2] [Reference Citation Analysis]
137 Gunia-Krzyżak A, Żesławska E, Słoczyńska K, Żelaszczyk D, Sowa A, Koczurkiewicz-Adamczyk P, Popiół J, Nitek W, Pękala E, Marona H. S(+)-(2E)-N-(2-Hydroxypropyl)-3-Phenylprop-2-Enamide (KM-568): A Novel Cinnamamide Derivative with Anticonvulsant Activity in Animal Models of Seizures and Epilepsy. Int J Mol Sci 2020;21:E4372. [PMID: 32575479 DOI: 10.3390/ijms21124372] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Zaccara G, Almas M, Pitman V, Knapp L, Posner H. Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial. Epilepsia 2014;55:1048-57. [DOI: 10.1111/epi.12679] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
139 Kubova H. Side Effects of Antiepileptic Drugs. In: Talevi A, Rocha L, editors. Antiepileptic Drug Discovery. New York: Springer; 2016. pp. 329-50. [DOI: 10.1007/978-1-4939-6355-3_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Żesławska E, Nitek W, Marona H, Gunia-Krzyżak A. Crystallographic studies of cinnamamide derivatives as a means of searching for anticonvulsant activity. Acta Crystallogr C Struct Chem 2017;73:953-9. [PMID: 29111525 DOI: 10.1107/S2053229617013845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
141 Lloyd KA. A scientific review: mechanisms of valproate-mediated teratogenesis. Bioscience Horizons 2013;6:hzt003-hzt003. [DOI: 10.1093/biohorizons/hzt003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
142 Mula M, von Oertzen TJ, Cock HR, Yogarajah M, Lozsadi DA, Agrawal N. Fatigue during treatment with antiepileptic drugs: A levetiracetam-specific adverse event? Epilepsy & Behavior 2017;72:17-21. [DOI: 10.1016/j.yebeh.2017.04.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Charalambous M, Shivapour SK, Brodbelt DC, Volk HA. Antiepileptic drugs' tolerability and safety--a systematic review and meta-analysis of adverse effects in dogs. BMC Vet Res 2016;12:79. [PMID: 27206489 DOI: 10.1186/s12917-016-0703-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 6.6] [Reference Citation Analysis]
144 Woo PY, Woo AW, Lam SW, Ko NM, Ho JW, Chu AC, Kwan MC, Chan Y, Wong H, Chan K. Incidence, Presentation, and Risk Factors for Sodium Valproate–Associated Hyperammonemia in Neurosurgical Patients: A Prospective, Observational Study. World Neurosurgery 2020;144:e597-604. [DOI: 10.1016/j.wneu.2020.09.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
145 Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 2009;50:1-23. [DOI: 10.1111/j.1528-1167.2008.01716.x] [Cited by in Crossref: 169] [Cited by in F6Publishing: 134] [Article Influence: 14.1] [Reference Citation Analysis]
146 Drokov AP, Lipatova LV, Shnayder NA, Nasyrova RF. Pharmacogenetic Markers for Metabolic Impairments in Treatment with Valproic Acid. Neurosci Behav Physi 2020;50:13-9. [DOI: 10.1007/s11055-019-00861-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Martins IL, Nunes J, Charneira C, Morello J, Pereira SA, Telo JP, Marques MM, Antunes AMM. The first-line antiepileptic drug carbamazepine: Reaction with biologically relevant free radicals. Free Radic Biol Med 2018;129:559-68. [PMID: 30342189 DOI: 10.1016/j.freeradbiomed.2018.10.408] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
148 Perucca P, Gilliam FG, Schmitz B. Epilepsy treatment as a predeterminant of psychosocial ill health. Epilepsy & Behavior 2009;15:S46-50. [DOI: 10.1016/j.yebeh.2009.03.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
149 Alvestad S, Lydersen S, Brodtkorb E. Cross-reactivity pattern of rash from current aromatic antiepileptic drugs. Epilepsy Research 2008;80:194-200. [DOI: 10.1016/j.eplepsyres.2008.04.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
150 Anderson GD, Hakimian S. Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment. Clin Pharmacokinet 2014;53:29-49. [PMID: 24122696 DOI: 10.1007/s40262-013-0107-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
151 van Gaalen RD, Abrahamowicz M, Buckeridge DL. The impact of exposure model misspecification on signal detection in prospective pharmacovigilance: IMPACT OF MODEL IN PHARMACOVIGILANCE. Pharmacoepidemiol Drug Saf 2015;24:456-67. [DOI: 10.1002/pds.3700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
152 Fricke-Galindo I, Jung-Cook H, LLerena A, López-López M. Pharmacogenetics of adverse reactions to antiepileptic drugs. Neurologia (Engl Ed) 2018;33:165-76. [PMID: 25976948 DOI: 10.1016/j.nrl.2015.03.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
153 Hung S, Chung W, Tsai J, Chen Y. Carbamazepine and Its Structurally-Related Antiepileptics. In: Wu AHB, Yeo KJ, editors. Pharmacogenomic Testing in Current Clinical Practice. Totowa: Humana Press; 2011. pp. 225-36. [DOI: 10.1007/978-1-60761-283-4_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
154 Krauss G, Biton V, Harvey JH, Elger C, Trinka E, Soares da Silva P, Gama H, Cheng H, Grinnell T, Blum D. Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials. Epilepsy Res 2018;139:1-8. [PMID: 29127848 DOI: 10.1016/j.eplepsyres.2017.10.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
155 Anderson GD. Pharmacokinetic, Pharmacodynamic, and Pharmacogenetic Targeted Therapy of Antiepileptic Drugs. Therapeutic Drug Monitoring 2008;30:173-80. [DOI: 10.1097/ftd.0b013e318167d11b] [Cited by in Crossref: 46] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
156 He N, Min FL, Shi YW, Guo J, Liu XR, Li BM, Zhou JH, Ou YM, Liao JX, Liao WP. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles. Seizure 2012;21:614-8. [PMID: 22818943 DOI: 10.1016/j.seizure.2012.06.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
157 Yasam VR, Jakki SL, Senthil V, Eswaramoorthy M, Shanmuganathan S, Arjunan K, Nanjan M. A pharmacological overview of lamotrigine for the treatment of epilepsy. Expert Review of Clinical Pharmacology 2016;9:1533-46. [DOI: 10.1080/17512433.2016.1254041] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]